Use of recombinant factor VIIa for major haemorrhage
- 1 July 2005
- journal article
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 22 (7) , 548-550
- https://doi.org/10.1017/s0265021505210943
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Cerebral Sinus Thrombosis in a Trauma Patient after Recombinant Activated Factor VII InfusionAnesthesiology, 2004
- ‘Last‐ditch’ use of recombinant factor VIIa in patients with massive haemorrhage is ineffectiveVox Sanguinis, 2004
- Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhageThrombosis Journal, 2004
- The Effect of Temperature and pH on the Activity of Factor VIIa: Implications for the Efficacy of High-Dose Factor VIIa in Hypothermic and Acidotic PatientsPublished by Wolters Kluwer Health ,2003
- NovoSeven® as a universal haemostatic agentBlood Coagulation & Fibrinolysis, 2000
- Recombinant Factor VIIa Does not Induce Hypercoagulability In VitroThrombosis and Haemostasis, 1999